COMMUNIQUÉS West-GlobeNewswire

AnswersNow Named Best Telehealth Platform in 2025 MedTech Breakthrough Awards
08/05/2025
Transformational virtual provider of autism therapy provides fast, convenient access to quality care for families everywhere RICHMOND, Va., May 08, 2025 (GLOBE NEWSWIRE) -- AnswersNow , the leader in virtual Applied [...]
Alpha Pro Tech, Ltd. Announces First Quarter 2025 Financial Results
08/05/2025
Total Sales Increased by 2.5% to $13.8 Million, Compared to the Prior Year Period Net sales for the first quarter of 2025 were $13.8 million, up 2.5%, compared to $13.5 million for the first quarter of 2024 Building [...]
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
08/05/2025
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs [...]
Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops
08/05/2025
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the [...]
LiveWorld Reports First Quarter 2025 Financial Results
08/05/2025
LiveWorld looks to increase its AI investment CAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for first quarter 2025. Three Months [...]
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
08/05/2025
- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron ® Chemotherapy Induced Neuropathic Pain Phase 2b Study - - Halneuron ® Chemotherapy Induced Neuropathic Pain Phase 2b study interim data readout [...]
Best Steroids For Cutting: Top Anabolic Steroid Stack For Cutting Cycles To Get Ripped And Shredded Muscles - Crazybulk
08/05/2025
Looking to get shredded? Learn which cutting steroids deliver fast fat loss and muscle definition. See the best stacks, real results, safety tips, and legal alternatives backed by Crazybulk. New York City, May 08, 2025 [...]
Best Legal Steroids (USA): Top 4 Anabolic Steroids For Muscle Growth & Natural Bodybuilding By Wolfson Brands
08/05/2025
Backed by Wolfson Brands (UK) Limited, discover the 4 best legal steroids in the USA for muscle growth and natural bodybuilding. Safe, effective, and 100% legal alternatives to anabolic steroids. Glasgow, May 08, 2025 ( [...]
GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
08/05/2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6- [...]
AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
08/05/2025
OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
08/05/2025
Please see enclosed pdf. Attachment 08052025_trading_in_shares_GL
Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202
08/05/2025
Video illustrates SENTI-202’s MoA, namely to selectively kill both AML blasts and leukemic stem cells (LSCs) while protecting healthy hematopoietic stem cells/ hematopoietic stem and progenitor cells (HSC/HSPCs) using [...]
Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
08/05/2025
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical [...]
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
08/05/2025
Prof. Lars Zender’s featured talk described HepaRegeniX’s lead candidate and its potential in increasing liver regeneration, from initial target discovery and drug development towards Phase Ia clinical trial results [...]
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
08/05/2025
Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R&D Day in March, Company is on track to initiate Phase 2 ASPEN-Breast and Phase 1 ASPEN-CRC [...]
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
08/05/2025
New patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit’s pipeline, unlocking up to 20 years of new IP runway and enabling enhanced formulation strategies to [...]
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
08/05/2025
Three-year program examined opportunities to integrate artificial intelligence technology into future generations of ReWalk Exoskeletons MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- [...]
Exagen Inc. Prices Public Offering of Common Stock
08/05/2025
CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3 [...]
Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration
08/05/2025
Meeting to Take Place on July 25, 2025 Meeting’s Purpose is To Discuss Upcoming Clinical Development Plan and Protocol Designs GLEN ALLEN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. ( NASDAQ: ADIL [...]

Pages